Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR–ABL kinase domain mutations affect patient survival? First multicenter Argentinean study
暂无分享,去创建一个
M. Bianchini | R. Bengió | I. Larripa | E. Bullorsky | J. Milone | B. Moiraghi | Verónica Ventriglia | E. Lanari | M. Riva | H. Murro | M. T. Tezanos pinto